With 4.08 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.37 million shares. The 52-week range on GEVO shows that it touched its highest point at $3.39 and its lowest point at $0.48 during that stretch. It currently has a 1-year price target of $4.90. Beta for the stock currently stands at 2.54.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GEVO was up-trending over the past week, with a rise of 15.53%, but this was up by 9.17% over a month. Three-month performance dropped to -32.77% while six-month performance fell -30.81%. The stock gained 59.56% in the past year, while it has lost -43.06% so far this year. A look at the trailing 12-month EPS for GEVO yields -0.33 with Next year EPS estimates of -0.18. For the next quarter, that number is -0.10. This implies an EPS growth rate of 21.07% for this year and 33.87% for next year. EPS is expected to grow by 19.88% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 32.11%.
Float and Shares Shorts:
At present, 239.18 million GEVO shares are outstanding with a float of 228.75 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GEVO since 2 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 1 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.3608 being high and -$0.38214 being low. For GEVO, this leads to a yearly average estimate of -$0.37147.
